COVID alters respiratory microbiota
Apr. 25, 2023—COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.
COVID-19 battle begins in the nose
Feb. 2, 2023—A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.
Vaccine effectiveness research continues to grow
Jan. 26, 2023—Vanderbilt's participation in vaccine effectiveness research continues to grow, with the Medical Center playing critical roles in several networks focused on surveillance of vaccine-preventable respiratory diseases.
Study to explore COVID’s impact on essential workers
Jan. 26, 2023—Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.
Emerging Infections Program lands national award for COVID response
Jan. 19, 2023—Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.
Flu season came early, hit hard in Tennessee
Dec. 21, 2022—Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.
VUMC to pilot CDC joint training program
Jun. 16, 2022—Vanderbilt University Medical Center is among 11 centers that will pilot a new federally sponsored training program, the Joint Infectious Diseases/Epidemic Intelligence Service (ID/EIS) Fellowship.
Pushing (anti-overdose) drugs
May. 23, 2022—An automated alert to encourage clinicians to coprescribe naloxone for patients at risk of opioid overdose increased naloxone prescriptions per opioid prescription 16-fold.
COVID-associated bleeding risk
May. 5, 2022—While case reports have noted acquired hemophilia after COVID-19 infection or vaccination, a new study finds no increased risk.
Monroe Carell Jr. Children’s Hospital at Vanderbilt/CDC investigate mysterious liver disease in children
Apr. 26, 2022—Physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are collaborating with the CDC and other hepatologists around the country to help figure out the origins of a mysterious liver disease affecting children ages 1 month to 16 years old.
AAMC launches Health Equity Inventory at VUMC
Apr. 21, 2022—The Association of American Medical Colleges (AAMC) has launched a pilot project with Vanderbilt University Medical Center to develop a cloud-based tool to inventory community-based activities to address health inequities.
VU, VUMC research funding surpasses $1 billion
Apr. 6, 2022—Vanderbilt University and Vanderbilt University Medical Center received more than $1 billion in research funding awarded from external organizations in 2021.